What are Neurocrine Biosciences's profit margins?

Neurocrine Biosciences (NBIX) runs a 98.2% gross margin and a 25.4% operating margin, with a 21.6% net margin.

Where do Neurocrine Biosciences's ratios come from?

Every ratio is computed from Neurocrine Biosciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Neurocrine Biosciences NBIX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	393.2%-0.7pp	393.6%+0.2pp	393.9%+1.2pp	394.1%+2.0pp	393.9%+2.1pp
Operating margin	87.3%-8.5pp	82.4%-16.4pp	85%-2.9pp	90.3%+16.8pp	95.8%+38.7pp
Net margin	68.1%+7.7pp	59.2%-7.1pp	57%-8.1pp	58.2%-0.3pp	60.4%+7.2pp
Returns
Return on equity	67.2%+8.7pp	57.2%-7.1pp	54.9%-7.8pp	56.3%-0.8pp	58.5%+6.1pp
Return on invested capital	56.6%-7.2pp	51.5%-17.8pp	52.3%-10.9pp	57.9%+4.6pp	63.8%+21.3pp
Efficiency
Asset turnover	2.8×0.0×	2.7×0.0×	2.7×0.0×	2.8×0.0×	2.8×0.0×
Liquidity
Current ratio	12.9×-2.2×	13.1×-1.4×	13.1×-0.4×	14.1×+2.5×	15.1×+5.2×
Leverage
Debt-to-equity	0.6×0.0×	0.7×+0.1×	0.7×+0.1×	0.7×0.0×	0.6×-0.1×
Net debt / EBITDA	0.5×-0.6×	0.8×+0.2×	1.6×+0.7×	1.3×+0.4×	1.1×-0.1×
Per Share
Book value per share	$120.67+20.8%	$112.46+14.5%	$105.69+10.8%	$102.46+15.0%	$99.93+19.8%
Valuation
Market capitalization	$53.97B+7.5%	$51.78B-2.2%	$51.46B-1.2%	$49.15B-4.5%	$50.2B+6.9%
Price / earnings	118.3×-28.9×	134.6×-13.8×	145.5×-14.3×	143.1×-44.3×	147.2×-52.0×
Price / sales	19.4×-2.6×	19.8×-4.7×	20.7×-4.8×	20.7×-5.8×	22.1×-3.4×
Price / book	17.6×-1.9×	18×-2.8×	19×-2.3×	18.7×-3.9×	19.4×-2.6×
EV / EBITDA	86.7×-2.4×	91.9×-3.8×	94.1×-26.4×	88.9×-61.5×	89×-91.9×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Neurocrine Biosciences.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Neurocrine Biosciences's profit margins?: Neurocrine Biosciences (NBIX) runs a 98.2% gross margin and a 25.4% operating margin, with a 21.6% net margin.
Where do Neurocrine Biosciences's ratios come from?: Every ratio is computed from Neurocrine Biosciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.